SCHEMBL4364264

SCHEMBL4364264

O=C(Nc1ccccc1)c1cncc(Br)c1Cl

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
MEN1 O00255 3/20 0.50
SMO Q99835 1/20 0.49
HSPD1 P10809 1/20 0.49
HSPE1 P61604 1/20 0.49
CYP11B2 P19099 1/20 0.48
JAK2 O60674 2/20 0.48
TYK2 P29597 1/20 0.48
ROCK2 O75116 1/20 0.48
ROCK1 Q13464 1/20 0.48
ALDH1A1 P00352 2/20 0.47
HTT P42858 2/20 0.47
USP2 O75604 2/20 0.47
TMPRSS4 Q9NRS4 1/20 0.47
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2892111 0.78 HTT (0.56) KMT2AMEN1HSPD1HSPE1CYP11B2
SCHEMBL31450301 0.75 HCAR2 (0.39) KMT2AMEN1ALDH1A1KDM4ELMNA
SCHEMBL3720517 0.75 HCAR2 (0.39) KMT2AMEN1ALDH1A1KDM4ELMNA
Hydrochloric Acid SCHEMBL9197573 0.74 ROCK2 (0.79) KMT2AMEN1SMOCYP11B2JAK2
SCHEMBL766990 0.74 HSPD1 (0.57) KMT2AMEN1HSPD1HSPE1ALDH1A1
SCHEMBL31582632 0.73 MAOB (0.35) ROCK2ROCK1POLB
SCHEMBL882734 0.73 KMT2A (0.80) KMT2AMEN1HSPD1HSPE1ALDH1A1
SCHEMBL3788790 0.73 ALDH1A1 (0.66) KMT2AMEN1SMOJAK2ALDH1A1
SCHEMBL8269199 0.72 TYK2 (0.60) SMOCYP11B2JAK2TYK2ALDH1A1
SCHEMBL28072777 0.72 JAK2 (0.67) KMT2AMEN1SMOCYP11B2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125780-A1 SUBSTITUTED HETEROCYCLES AND METHODS OF USE Amgen Inc. (US) 2009-12-02 EP disclosed
WO-2008079294-A1 SUBSTITUTED HETEROCYCLES AND METHODS OF USE AMGEN INC. (US) 2008-07-03 WO disclosed